Creation of synthetic horsepox virus could lead to more effective smallpox vaccine

January 19, 2018, University of Alberta Faculty of Medicine & Dentistry
David Evans and Ryan Noyce have created a new synthetic virus they hope could lead to the development of a more effective vaccine against smallpox. Credit: Melissa Fabrizio

UAlberta researchers created a new synthetic virus that could lead to the development of a more effective vaccine against smallpox. The discovery demonstrates how techniques based on the use of synthetic DNA can be used to advance public health measures.

Virologist David Evans and his research associate Ryan Noyce produced an infectious horsepox virus, which they synthetically reconstructed using a published genome sequence and DNA fragments manufactured entirely by chemical methods. The team went on to show that the synthetic horsepox virus could provide vaccine protection in a mouse model of poxvirus infection.

"This application of synthetic DNA technology has the potential to revolutionize how we manufacture complex biologicals including recombinant viruses," said Evans, a professor of microbiology and member of the Li Ka-Shing Institute of Virology.

"These methods advance the capacity to produce next-generation vaccines and offer special promise as a tool for constructing the complicated synthetic viruses that will likely be needed to treat cancer," said David Evans.

The horsepox virus U of A researchers synthesized is the largest virus assembled to date using chemically synthesized DNA. Horsepox?an equine disease caused by horsepox virus?is not a hazard to humans. It is closely related to vaccinia virus, the virus that was used as a vaccine to eradicate human smallpox 40 years ago. While there have been no cases of naturally occurring smallpox since 1977, it remains a concern to public health agencies.

Tonix Pharmaceuticals Holding Corp. is developing the synthetic version of horsepox as a potential vaccine to prevent smallpox (variola virus) infection in humans. Seth Lederman, President and Chief Executive Office of Tonix, is co-investigator on the research and co-inventor on the designated TNX-801 patent.

"Tonix's goal is to develop a vaccine that has a better safety profile than the current vaccines for broader usage and to provide greater protection to the public," said Lederman.

Current smallpox vaccines are used to protect first responders and military service members but are rarely used except in special circumstances. Because of the toxicity of most modern smallpox vaccines, Canada and the United States have long discontinued immunizing whole populations, as was the policy prior to smallpox eradication.

Evans hopes the research will contribute to informed discussions relating to the potential applications of synthetic biology for the benefit of society.

His U of A research team had previously used more traditional recombinant DNA technologies to engineer a vaccinia virus with the aim of improving the treatment for bladder cancer.

The virus is an oncolytic virus, which means it was modified to selectively kill rapidly-dividing cancer cells while remaining safe for surrounding healthy cells. In pre-clinical models these viruses can infect and kill cancer cells, while promoting the development of an immune response that is needed to prevents the cancer from returning. However, future generations of oncolytic viruses will require a greater degree of modification than is possible using older technologies. Synthetic biology offers a powerful tool for manufacturing these more complicated biological therapeutics.

"We are invested as a research laboratory in taking that same technology and applying it to other poxviruses," said Evans.

The work of assembling TNX-801 was funded by a research contract from Tonix Pharmaceuticals, but was made possible by a long history of grant funding from the Canadian Institutes of Health Research (CIHR) and the Natural Sciences and Engineering Research Council (NSERC).

The study was published in PLOS ONE.

Explore further: New clues on the history of the smallpox vaccine virus

More information: Noyce RS, Lederman S, Evans DH (2018) Construction of an infectious horsepox virus vaccine from chemically synthesized DNA fragments. PLoS ONE 13(1): e0188453. doi.org/10.1371/journal.pone.0188453

Related Stories

New clues on the history of the smallpox vaccine virus

September 22, 2015
Smallpox - simply hearing the word evokes images of countless people suffering gruesome deaths throughout recorded history. Known scientifically as variola, the virus had 30 percent mortality rate and survivors were branded ...

Lactic acid bacteria can protect against Influenza A virus, study finds

December 13, 2017
Lactic acid bacteria, commonly used as probiotics to improve digestive health, can offer protection against different subtypes of influenza A virus, resulting in reduced weight loss after virus infection and lower amounts ...

Researchers develop 'SMART' vaccines that are safe, effective

September 5, 2013
(Medical Xpress)—The question facing pathobiologist Paulo Verardi is not whether vaccines are effective in controlling disease – they are – it is how they can be made both highly safe and highly effective at the same ...

Development of a novel vaccine for Zika

June 5, 2017
Research presented by Farshad Guirakhoo, Ph.D., Chief Scientific Officer, GeoVax, Inc., at the ASM Microbe 2017 meeting showed a new Zika virus vaccine that gives 100% protection in mice. The vaccine is the first to be based ...

Recommended for you

Building better tiny kidneys to test drugs and help people avoid dialysis

February 16, 2018
A free online kidney atlas built by USC researchers empowers stem cell scientists everywhere to generate more human-like tiny kidneys for testing new drugs and creating renal replacement therapies.

Expanding Hepatitis C testing to all adults is cost-effective and improves outcomes

February 16, 2018
According to a new study, screening all adults for hepatitis C (HCV) is a cost-effective way to improve clinical outcomes of HCV and identify more infected people compared to current recommendations. Using a simulation model, ...

Study suggests expanded range for emerging tick-borne disease

February 16, 2018
Human cases of Borrelia miyamotoi, a tick-borne infection with some similarities to Lyme disease, were discovered in the eastern United States less than a decade ago. Now new research led by the Yale School of Public Health ...

Flu shot only 36 percent effective, making bad year worse (Update)

February 15, 2018
The flu vaccine is doing a poor job protecting older Americans and others against the bug that's causing most illnesses.

IFN-mediated immunity to influenza A virus infection influenced by RIPK3 protein

February 15, 2018
Each year, influenza kills half a million people globally with the elderly and very young most often the victims. In fact, the Centers for Disease Control and Prevention reported 37 children have died in the United States ...

A new class of drug to treat herpes simplex virus-1 infection

February 14, 2018
For patients with the herpes simplex-1 virus (HSV-1), there are just a handful of drugs available to treat the painful condition that can affect the eyes, mouth and genitals.

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

rrwillsj
5 / 5 (1) Jan 20, 2018
Immunize or die. Been a truism since the 1700's.

Not to say there have not been problems, some resolved, some not. And that we can expect new problems in the future.

There's no such thing as a 100% perfect, a 100% safe with anything. Especially with the chaotic crapshoot of biology!

For all that some people may (or believe) suffer side-effects or toxic reactions to immunization. Public opinion is muddled with the clamor of cranks, frauds, and desperate people demanding scapegoats.

It is evident that for the great majority of people, immunizations are an inexpensive and safe way to prevent the spread of communicable diseases.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.